Recombinant Flagellin-Porcine Circovirus Type 2 Cap Fusion Protein Promotes Protective Immune Responses in Mice

Flagellin-HA vaccines protect ferrets and mice against H5N1 highly pathogenic avian influenza virus (HPAIV) infections

(2012) Ge Liu et al.   VACCINE

Enhanced protective immune response to PCV2 subunit vaccine by co-administration of recombinant porcine IFN-γ in mice

(2012) Yi-Ping Wang et al.   VACCINE

Enhanced Antigen Processing of Flagellin Fusion Proteins Promotes the Antigen-Specific CD8+ T Cell Response Independently of TLR5 and MyD88

(2011) J. T. Bates et al.   JOURNAL OF IMMUNOLOGY

Construction and immunogenicity of recombinant adenovirus expressing ORF2 of PCV2 and porcine IFN gamma

(2011) Liu Genmei et al.   VACCINE

TLR5 functions as an endocytic receptor to enhance flagellin-specific adaptive immunity

(2010) Shirdi E. Letran et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Flagellin as an Adjuvant: Cellular Mechanisms and Potential

(2010) S. B. Mizel et al.   JOURNAL OF IMMUNOLOGY

Immunity conferred by an experimental vaccine based on the recombinant PCV2 Cap protein expressed in Trichoplusia ni-larvae

(2010) Eva Pérez-Martín et al.   VACCINE

One dose of a porcine circovirus 2 subunit vaccine induces humoral and cell-mediated immunity and protects against porcine circovirus-associated disease under field conditions

(2010) Paolo Martelli et al.   VETERINARY MICROBIOLOGY

A Recombinant Flagellin-Poxvirus Fusion Protein Vaccine Elicits Complement-Dependent Protection Against Respiratory Challenge with Vaccinia Virus in Mice

(2010) Kristen N. Delaney et al.   VIRAL IMMUNOLOGY

Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research

(2010) Carol Kilkenny et al.   PLOS BIOLOGY

The optimized capsid gene of porcine circovirus type 2 expressed in yeast forms virus-like particles and elicits antibody responses in mice fed with recombinant yeast extracts

(2009) Sergio A. Bucarey et al.   VACCINE

One dose of a porcine circovirus 2 (PCV2) sub-unit vaccine administered to 3-week-old conventional piglets elicits cell-mediated immunity and significantly reduces PCV2 viremia in an experimental model

(2009) M. Fort et al.   VACCINE

Bordetella bronchiseptica aroA mutant as a live vaccine vehicle for heterologous porcine circovirus type 2 major capsid protein expression

(2009) Taejung Kim et al.   VETERINARY MICROBIOLOGY

Flagellin-F1-V Fusion Protein Is an Effective Plague Vaccine in Mice and Two Species of Nonhuman Primates

(2008) S. B. Mizel et al.   Clinical and Vaccine Immunology

Protective immunity against porcine circovirus 2 by vaccination with ORF2-based DNA and subunit vaccines in mice

(2008) H.-G. Shen et al.   JOURNAL OF GENERAL VIROLOGY

Construction and immunogenicity of recombinant pseudotype baculovirus expressing the capsid protein of porcine circovirus type 2 in mice

(2008) Huiying Fan et al.   JOURNAL OF VIROLOGICAL METHODS

Expression of the capsid protein of porcine circovirus type 2 in Lactococcus lactis for oral vaccination

(2008) Ke Wang et al.   JOURNAL OF VIROLOGICAL METHODS

Mucosal adjuvant activity of flagellin in aged mice

(2008) John T. Bates et al.   MECHANISMS OF AGEING AND DEVELOPMENT

Porcine circovirus type 2 (PCV2) vaccination of conventional pigs prevents viremia against PCV2 isolates of different genotypes and geographic origins

(2008) M. Fort et al.   VACCINE

Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2

(2008) Marion Kixmöller et al.   VACCINE

Comparison of efficacy of commercial one dose and two dose PCV2 vaccines using a mixed PRRSV–PCV2–SIV clinical infection model 2–3-months post vaccination

(2008) T. Opriessnig et al.   VACCINE